The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

Indiana University is leading the way in the development of groundbreaking nanotechnology to revolutionize screening for prostate cancer, the second leading cause of cancer death among men in the ...

ARE TREATED FOR THE DISEASE. IT IS A VERY EXCITING TIME TO DO CANCER RESEARCH. DR. PHILIPPE DE CARVALHO HAS A HUGE REASON TO BE EXCITED ABOUT CANCER RESEARCH, SPECIFICALLY PROSTATE CANCER RESEARCH AND ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men. The research, published in the ...

Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...

Article ‘Count’ and ‘Share’ for Australian Prostate Cancer Research Centre - Queensland (APCRC - Q) based on listed parameters only. According to the parameters selected above, there are no articles ...

While most prostate cancers grow slowly, some may classify as aggressive prostate cancers based on stage and grade. Prostate cancers mostly consist of adenocarcinomas, which develop within the ...